"Cook Children's Hematology and Oncology is working every day to treat and cure blood disorders and cancers in children and teens."

During the past decade, Cook Children's Hematology and Oncology Center conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Cook Children's Hematology and Oncology Center" are "Anemia, Sickle Cell" (1 trials), "CD33 Positive Acute Myelogenous Leukemia" (1 trials), "Neoplasms" (1 trials), "Neuroblastoma" (1 trials) and "Neuroectodermal Tumors" (1 trials). Many other conditions were trialed in "Cook Children's Hematology and Oncology Center" in a lesser frequency.

Most popular intervention types in "Cook Children's Hematology and Oncology Center" are "Drug" (3 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Rivipansel" (2 trials), "131-MIBG + Vorinostat" (1 trials), "131I-MIBG" (1 trials), "Antibody Drug Conjugate Chemotherapeutic" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cook Children's Hematology and Oncology Center" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Cook Children's Hematology and Oncology Center". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Cook Children's Hematology and Oncology Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Cook Children's Hematology and Oncology Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".